Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CanTEN Trial
NCT07788586Phase 4Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 4 trial of caspofungin in candidemia, invasive candidiasis. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
caspofungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NCT07788586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07788586.